Roger Malerbakken Bjerke
Roger Malerbakken Bjerke publishes mostly in Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology, on topics such as Radiopharmaceutical Chemistry and Applications, Prostate Cancer Treatment and Research and Occupational and environmental lung diseases.
- World rank
- #1,184,767 of 7,710,434 ranked researchers
- Rank in Norway
- #7,510 of 33,005
- Works
- 107
- Citations
- 1.1k
- Citations per work
- 10.0
What does Roger Malerbakken Bjerke research?
Roger Malerbakken Bjerke's work is mostly in Medicine (66%), Biochemistry, Genetics and Molecular Biology (9%), Chemistry (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences7166.1%
- Medicine7166.1%
- Everything else2119.6%
- Life Sciences109.0%
- Physical Sciences65.3%
- Chemistry65.3%
- 1Radiology, Nuclear Medicine and Imaging33% of their works
- 2Pulmonary and Respiratory Medicine20% of their works
- 3Oncology14% of their works
- 4Molecular Biology9% of their works
- 5Spectroscopy3% of their works
- 6Organic Chemistry2% of their works
Research topics
- Radiopharmaceutical Chemistry and Applications
- Prostate Cancer Treatment and Research
- Occupational and environmental lung diseases
- Medical Imaging Techniques and Applications
- DNA Repair Mechanisms
- Mass Spectrometry Techniques and Applications
- Lung Cancer Treatments and Mutations
- Fibroblast Growth Factor Research
Which keywords describe Roger Malerbakken Bjerke's research?
The keywords of their largest research topics: Targeted Therapy, PET Imaging, Radiopharmaceuticals, Immunotherapy, Clinical Trials, Genomic Profiling, Cancer and Androgen Receptor.
- Fibroblast Growth Factor
- Repair
- Ionization
- DNA Damage
- tumor
- Malignant Pleural Mesothelioma
- Prostate Cancer
- Androgen Receptor
- Genomic Profiling
- Immunotherapy
- PET Imaging
- Targeted Therapy
- Radiopharmaceuticals
- Clinical Trials
- Cancer
- Imaging
- BAP1 mutations
- PET/CT
- ALK Inhibitors
- EGFR Mutations
- Mass Spectrometry
- FGF21
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 22 words, with their numbers
- Targeted Therapy382 topics
- PET Imaging341 topic
- Radiopharmaceuticals341 topic
- Immunotherapy142 topics
- Clinical Trials132 topics
- Genomic Profiling132 topics
- Cancer123 topics
- Androgen Receptor91 topic
- Imaging92 topics
- Prostate Cancer91 topic
- BAP1 mutations51 topic
- Malignant Pleural Mesothelioma51 topic
- PET/CT51 topic
- tumor51 topic
- ALK Inhibitors41 topic
- DNA Damage41 topic
- EGFR Mutations41 topic
- Ionization41 topic
- Mass Spectrometry41 topic
- Repair41 topic
- FGF2131 topic
- Fibroblast Growth Factor31 topic
Where does Roger Malerbakken Bjerke work?
Roger Malerbakken Bjerke's main affiliation in the publication record is Bayer (Norway), Norway.
How many publications and citations does Roger Malerbakken Bjerke have?
OpenAlex counts 107 works and 1,070 citations for Roger Malerbakken Bjerke, an h-index of 14, ranking #1,184,767 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Roger Malerbakken Bjerke. Posts are plain text and can be reported.